Stocks News

LAST PRICE
985.0200
TODAY'S CHANGE (%)
Trending Up4.4500 (0.4538%)

Bid / Lots
965.0000/ 1
Ask / Lots
1,098.9300/ 1
Open / Previous Close
984.0400 / 980.5700
Day Range
Low 983.1600
High 995.4050
52 Week Range
Low 684.8050
High 998.3250
Volume
259,279
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- Regeneron Pharmaceuticals, Inc. (REGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings, from 12 hours ago by Dow Jones
  12 hours ago by Dow Jones
  Companies Mentioned: REGN
  
  NEW YORK, NY / ACCESSWIRE / May 27, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") (NASDAQ:REGN). Investors who purchased Regeneron securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: https://bgandg.com/REGN/.
Yesterday
- INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 11:06AM ET on Sunday May 26, 2024 by Dow Jones
  11:06AM ET on Sunday May 26, 2024 by Dow Jones
  Companies Mentioned: REGN
  
  LOS ANGELES, CA / ACCESSWIRE / May 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") (NASDAQ:REGN) for violations of the securities laws.
- Regeneron Pharmaceuticals, Inc. (REGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings, from 11:02AM ET on Sunday May 26, 2024 by Dow Jones
  11:02AM ET on Sunday May 26, 2024 by Dow Jones
  Companies Mentioned: REGN
  
  NEW YORK, NY / ACCESSWIRE / May 26, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") (NASDAQ:REGN). Investors who purchased Regeneron securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: https://bgandg.com/REGN/.
May 25, 2024
- IMPORTANT INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 11:07AM ET on Saturday May 25, 2024 by Dow Jones
  11:07AM ET on Saturday May 25, 2024 by Dow Jones
  Companies Mentioned: REGN
  
  LOS ANGELES, CA / ACCESSWIRE / May 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") (NASDAQ:REGN) for violations of the securities laws.
May 24, 2024
- SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 12:49PM ET on Friday May 24, 2024 by Dow Jones
  12:49PM ET on Friday May 24, 2024 by Dow Jones
  Companies Mentioned: REGN
  
  LOS ANGELES, CA / ACCESSWIRE / May 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") (NASDAQ:REGN) for violations of the securities laws.

May 24, 2024
- Vertex Pharmaceuticals Insider Sold Shares Worth $3,168,704, According to a Recent SEC Filing, from 4:16PM ET on Friday May 24, 2024 by MT Newswires
  4:16PM ET on Friday May 24, 2024 by MT Newswires
  Companies Mentioned: VRTX
May 22, 2024
- Vertex Pharmaceuticals Insider Sold Shares Worth $6,795,294, According to a Recent SEC Filing, from 4:28PM ET on Wednesday May 22, 2024 by MT Newswires
  4:28PM ET on Wednesday May 22, 2024 by MT Newswires
  Companies Mentioned: VRTX
- US Equity Markets Close Down Wednesday After Fed Minutes Raise Inflation Concerns, from 4:06PM ET on Wednesday May 22, 2024 by MT Newswires
  4:06PM ET on Wednesday May 22, 2024 by MT Newswires
  Companies Mentioned: PDD, BIIB
- Vertex to Participate in Upcoming June Investor Conferences, from 4:05PM ET on Wednesday May 22, 2024 by Business Wire
  4:05PM ET on Wednesday May 22, 2024 by Business Wire
  Companies Mentioned: VRTX
- Sector Update: Health Care Stocks Slightly Higher Late Afternoon, from 4:02PM ET on Wednesday May 22, 2024 by MT Newswires
  4:02PM ET on Wednesday May 22, 2024 by MT Newswires
  Companies Mentioned: PFE, AVXL, BIIB, AMPH
- Sector Update: Health Care Stocks Advance Wednesday Afternoon, from 2:01PM ET on Wednesday May 22, 2024 by MT Newswires
  2:01PM ET on Wednesday May 22, 2024 by MT Newswires
  Companies Mentioned: BIIB, LFST, AMPH
- Sector Update: Health Care, from 1:35PM ET on Wednesday May 22, 2024 by MT Newswires
  1:35PM ET on Wednesday May 22, 2024 by MT Newswires
  Companies Mentioned: BIIB
- Biogen Agrees to Buy Human Immunology Biosciences For up to $1.8 Billion, from 12:42PM ET on Wednesday May 22, 2024 by MT Newswires
  12:42PM ET on Wednesday May 22, 2024 by MT Newswires
  Companies Mentioned: BIIB
- Top Midday Stories: US Targets August 1 Start Date for China Tariff Hikes; CFPB Says BNPL Requires Credit Card-Level Oversight; Target Shares Fall on Earnings Miss; Third BHP Bid Rejected by Anglo American, from 12:24PM ET on Wednesday May 22, 2024 by MT Newswires
  12:24PM ET on Wednesday May 22, 2024 by MT Newswires
  Companies Mentioned: JNJ, NVDA, TSLA, TGT, AMZN, DOCU, PDD, BHP, BIIB, GOOG
- Wedbush Raises Biogen Price Target to $219 From $215, Maintains Neutral Rating, from 9:49AM ET on Wednesday May 22, 2024 by MT Newswires
  9:49AM ET on Wednesday May 22, 2024 by MT Newswires
  Companies Mentioned: BIIB

Regeneron Pharmaceuticals Inc
NASDAQ:REGNUnited States

Search Criteria

Today

Regeneron Pharmaceuticals, Inc. (REGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings, from 12 hours ago by Dow Jones

Yesterday

INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 11:06AM ET on Sunday May 26, 2024 by Dow Jones

Regeneron Pharmaceuticals, Inc. (REGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings, from 11:02AM ET on Sunday May 26, 2024 by Dow Jones

May 25, 2024

IMPORTANT INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 11:07AM ET on Saturday May 25, 2024 by Dow Jones

May 24, 2024

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm, from 12:49PM ET on Friday May 24, 2024 by Dow Jones

Peers Headlines

May 24, 2024

Vertex Pharmaceuticals Insider Sold Shares Worth $3,168,704, According to a Recent SEC Filing, from 4:16PM ET on Friday May 24, 2024 by MT Newswires

May 22, 2024

Vertex Pharmaceuticals Insider Sold Shares Worth $6,795,294, According to a Recent SEC Filing, from 4:28PM ET on Wednesday May 22, 2024 by MT Newswires

US Equity Markets Close Down Wednesday After Fed Minutes Raise Inflation Concerns, from 4:06PM ET on Wednesday May 22, 2024 by MT Newswires

Vertex to Participate in Upcoming June Investor Conferences, from 4:05PM ET on Wednesday May 22, 2024 by Business Wire

Sector Update: Health Care Stocks Slightly Higher Late Afternoon, from 4:02PM ET on Wednesday May 22, 2024 by MT Newswires

Sector Update: Health Care Stocks Advance Wednesday Afternoon, from 2:01PM ET on Wednesday May 22, 2024 by MT Newswires

Sector Update: Health Care, from 1:35PM ET on Wednesday May 22, 2024 by MT Newswires

Biogen Agrees to Buy Human Immunology Biosciences For up to $1.8 Billion, from 12:42PM ET on Wednesday May 22, 2024 by MT Newswires

Top Midday Stories: US Targets August 1 Start Date for China Tariff Hikes; CFPB Says BNPL Requires Credit Card-Level Oversight; Target Shares Fall on Earnings Miss; Third BHP Bid Rejected by Anglo American, from 12:24PM ET on Wednesday May 22, 2024 by MT Newswires

Wedbush Raises Biogen Price Target to $219 From $215, Maintains Neutral Rating, from 9:49AM ET on Wednesday May 22, 2024 by MT Newswires